Letter to the Editor
- PMID: 39171659
- PMCID: PMC11635798
- DOI: 10.1002/lsm.23832
Letter to the Editor
Conflict of interest statement
Conflicts of Interest
The authors declare no conflicts of interest.
References
-
- Gao C, Nguyen V, Hochman ML, et al., “Current Clinical Evidence is Insufficient to Support HMME-PDT as the First Choice of Treatment for Young Children With Port Wine Birthmarks,” Lasers in Surgery and Medicine 56 (2024): 321–333. - PubMed
-
- Zhang Y, Zou X, Chen H, Yang Y, Lin H, and Guo X, “Clinical Study on Clinical Operation and Post-Treatment Reactions of HMME-PDT in Treatment of PWS,” Photodiagnosis and Photodynamic Therapy 20 (2017): 253–256. - PubMed
-
- Yuan KH, Li Q, Yu WL, Zeng D, Zhang C, and Huang Z, “Comparison of Photodynamic Therapy and Pulsed Dye Laser in Patients With Port Wine Stain Birthmarks: A Retrospective Analysis,” Photodiagnosis and Photodynamic Therapy 5 (2008): 50–57. - PubMed
-
- Gu Y, Huang NY, Liang J, Pan YM, and Liu FG, “Analyse clinique de 1 949 angiomes plans traités par thérapie photodynamique vasculaire (Gu’s PDT),” Annales de Dermatologie et de Vénéréologie 134 (2007): 241–244. - PubMed
-
- Li-Qiang G, Hua W, Si-Li N, and Chun-Hua T, “A Clinical Study of HMME-PDT Therapy in Chinese Pediatric Patients With Port-Wine Stain,” Photodiagnosis and Photodynamic Therapy 23 (2018): 102–105. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AR068067/AR/NIAMS NIH HHS/United States
- R01 AR073172/AR/NIAMS NIH HHS/United States
- R21 AR083066/AR/NIAMS NIH HHS/United States
- This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (R01AR073172 and 1R21AR083066 to W.T.) and the Department of Defense (HT9425-23-10008 to W.T.).